ROIV — Roivant Sciences Ltd.
Healthcare • Biotechnology
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid...…
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
Price
Showing 5Y history. Source: FMP historical price full.
- Prev Close
- $20.24
- Day High
- $22.05
- Day Low
- $20.25
- 52w High
- $22.05
- 52w Low
- $8.73
- Volume
- 13,870,401
- Avg Volume
- Beta
- 1.227
* TTM/most recent where available
Company
- Ticker
- ROIV
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- GB
- CEO
- Matthew Gline
- Employees
- 908
- Website
- roivant.com
Key Metrics
- Market Cap
- 14.8B
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).